Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0596263 (
carcinogenesis
)
64,820
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Colorectal carcinoma was induced in Sprague-Dawley rats by 20-methylcholanthrene. Macroscopical studies revealed that the tumors, either sessile type or semi-pedunculated polyp, were generally observed after 32 weeks of the carcinogen treatment. In the distal colon 46.9% tumors appeared, whereas 20.4% and 32.6% tumors were found in the rectum and proximal colon, respectively. Sequential histopathological studies indicated that hyperplasia of goblet cells was common in early stages, which was reduced thereafter.
Carcinogenesis
progressed with the appearance of the different grades of dysplasia in colorectal mucosa with first incidence of the severe dysplasia in rats at the 20th week and in situ carcinoma at the close of 28th week. Most of the carcinomas were multifocal in origin and were well differentiated adenocarcinoma with primary invasion at the submucosa. In immunohistological studies, this carcinoma was also reactive with monoclonal antibody 660, prepared against a colorectal carcinoma associated
mucin
antigen.
...
PMID:Induction of colorectal cancer in rats by 20-methylcholanthrene. 173 Jan 42
Since the 1960s, the loss of sulfomucin from colonic epithelium has been considered to be an indicator of an early stage of
carcinogenesis
; yet, the biochemical basis for this phenomenon has never been elucidated. We recently prepared a monoclonal antibody (mAb) 91.9H that immunoprecipitates the normal colonic mucins metabolically incorporating [35S]-sulfate. This mouse IgG1 antibody did not cross-react with colon carcinoma mucins that lack sulfate groups. Using normal colonic epithelia unlabeled or radiolabeled with [35S]sulfate and [3H]glucosamine, we purified a high molecular weight glycoprotein that reacts with mAb 91.9H. This was achieved by a combination of DEAE-cellulose anion-exchange chromatography, consecutive treatments with chondroitinase ABC plus heparitinase and with sodium dodecyl sulfate plus 2-mercaptoethanol, and gel filtration on Sepharose CL-2B in the presence of 8 M urea. Antibody reactivity was found in acidic but not neutral high molecular weight glycoproteins. After Sepharose CL-2B fractionation, the mAb 91.9H-reactive fractions consisted of a component with an approximate molecular weight of 500,000-900,000. A purified sulfomucin contained protein, neutral sugar, amino sugar, sialic acid, and sulfate in an approximate ratio of 2.5:1.0:1.1:0.4:0.5. The polypeptide portion was rich in hydrophilic amino acids, particularly threonine. Binding of mAb 91.9H in solid-phase assays was inhibited to 50% by purified normal colon acidic
mucin
at doses of 5-50 micrograms/ml, depending on different preparations. Various glycosaminoglycans or sulfatides did not show inhibitory activity. Sulfomucin reactivity with mAb 91.9H, as determined by solid-phase-binding inhibition and by dot blot assays, was significantly reduced by chemical desulfation of sulfomucins with anhydrous hydrochloric acid, suggesting that sulfate groups served as a portion of the immunochemical determinant for this antibody. Sulfate residues were apparently linked to alkaline-sensitive carbohydrate chains, but alkaline-released carbohydrate chains did not react with mAb 91.9H. Immunohistochemical examinations showed that mAb 91.9H bound normal colonic epithelial cells, which also stained with high-iron diamine, more strongly than it bound colon carcinoma cells.
...
PMID:Human colonic sulfomucin identified by a specific monoclonal antibody. 191 91
The gastric mucin M1 antigens, markers associated with colonic
carcinogenesis
, have been characterized by new antimucin monoclonal antibodies (MAbs). These MAbs, obtained against mucins isolated from a human ovarian mucinous cyst (MAbs 19M1, 21M1 and 45M1) and from a pancreatic adenocarcinoma (MAb 96RA), were compared with 5 other anti-M1
mucin
MAbs described previously, which characterized the a, b, c, d and e
mucin
M1 epitopes. Using immunoperoxidase, these new MAbs exclusively stained the surface gastric epithelium of normal human gastro-intestinal tract and reacted with fetal, precancerous and cancerous colonic mucosa, but not with normal colon. Immunoradiofixation studies showed that these new MAbs are directed against 3 epitopes (f, g and h) which are different from the a, b, c, d and e
mucin
M1 epitopes, though present on the same a immunoreactive high-molecular-weight components (greater than 1,000 kDa) with a density of 1.4 by CsCl-density-gradient ultracentrifugation. M1 antigenicity is characterized by a family of 8 different M1 epitopes which were destroyed with beta-mercaptoethanol (except for the f epitope), sensitive to a 5 hr trypsin treatment and resistant to 5 mM periodate (except for the h epitope). Some epitopes (b, c and d) showed increasing immunoreactivity after 20 mM periodate treatment, suggesting cryptic location. In rat-colon adenocarcinomas, M1
mucin
epitopes were masked but could be decrypted using high periodate treatment, similar to normal rat gastric mucosa, thus suggesting the absence of drastic changes in the saccharide coat of the peptide
mucin
portion bearing M1 epitopes. Cryptic location, periodate resistance, sensitivity to protease and conformational behavior strongly suggest that the peptidic core of gastric (or fetal colonic)
mucin
plays a role in M1 immunoreactivity. Indeed, the resurgence of M1 antigens during colonic
carcinogenesis
is due to re-expression of the peptide core of gastric (or fetal colonic) mucins.
...
PMID:Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. 198 72
Carcinogenicity studies of the fecal mutagen fecapentaene-12 (FP-12) have been hampered because of its apparent instability. We report here that: (i) contrary to the popular belief, FP-12 is quite stable, particularly at micromolar to nanomolar concentration; and (ii) its characteristic spectrophotometric absorbance spectrum is a function of the solvent or vehicle. Using synchronous fluorescence spectrophotometry (SFS), we have determined that at delta lambda 36.5 nm FP-12 gives a characteristic single emission peak between 413 and 423 nm, allowing us to identify FP-12 in DNA when reacted in vitro. We also report an increased incidence (statistically not significant) of fibrosarcomas and mammary carcinomas in male F-344 rats following intrarectal instillation of FP-12. In the in vitro human colon explant model, direct addition of FP-12 results in alteration in
mucin
histochemical changes typical of precancer and cancer. Our results support the contention that FP-12 is a naturally occurring carcinogen and may be responsible for human cancer(s).
Carcinogenesis
1991 Apr
PMID:Stability of fecapentaene-12 and its carcinogenicity in F-344 rats. 201 24
Mucin histochemistry of experimental gastric cancers induced in rats by N-methyl-N'-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide was analysed by labelled lectin staining for concanavalin A (Con A) after prior periodate oxidation (paradoxical Con A staining) or Arachis hypogarea agglutinin (peanut lectin, PNA) with or without prior periodate oxidation. In the digestive tracts of control-group rats the mucins were classified into class II or III by paradoxical Con A staining. Class II mucins were found in surface mucous cells, goblet cells and the surface coat of intestinal absorptive cells, while class III mucins were present in mucous neck cells, pyloric gland cells and Brunner's gland cells. Although class III mucins showed PNA reactivity, those in pyloric gland cells selectively lost positive staining after 1-4 h oxidation with periodate. Thus phenotypic expression of class III
mucin
-positive cells in the gastric mucosa could be further classified into mucous-neck-cell type and pyloric-gland-cell type on the basis of this sensitivity to periodate oxidation. Metaplastic cells in fundic mucosa and almost all class III
mucin
-positive cells in adenomatous hyperplasias, well-differentiated adenocarcinomas and signet-ring cell carcinomas, which developed in both fundic and pyloric mucosae, showed pyloric gland phenotypic expression.
Carcinogenesis
1989 Jun
PMID:Pyloric gland phenotypic expression of gastric cancers developing in the rat fundic glandular stomach. 249 99
Proliferation of endocrine cells was found to occur during early, i.e., first 12 weeks, exocrine pancreatic
carcinogenesis
after 6 weekly treatments of Syrian hamsters with the pancreatic carcinogen N-nitrosobis(2-oxopropyl)amine (BOP). Cells containing insulin (Ins), glucagon (Glu), and somatostatin (Som) were noted in all stages of tumor development and were present in adenocarcinomas and in metastases to the liver. Some of the cancer cells were of amphicrine (hybrid) type, i.e., produced both
mucin
and endocrine substances. Measurement of these hormones revealed a significant decrease in plasma Ins during early stages of
carcinogenesis
with concomitant increase of Ins level in pancreatic juice at 12 weeks after 6 weekly BOP treatments. Plasma Glu and Som were not changed. The changes noted, particularly in relation to Ins, suggest that proliferation of endocrine cells in pancreatic
carcinogenesis
may be associated with alterations in hormone secretion.
...
PMID:Alteration of pancreatic endocrine cell patterns and their secretion during pancreatic carcinogenesis in the hamster model. 257 21
Although only a small proportion of patients with ulcerative colitis (UC) will develop cancer, colorectal carcinoma is still an important complication of UC. Traditionally, histopathological dysplasia has been used as a marker for colorectal
carcinogenesis
in patients with UC, however, wide within- and between-observer disagreements regarding the grading of dysplasia have become evident of late. Recently,
mucin
histochemistry, autoradiography and flow cytometric or static cytophotometric DNA analysis have been used for monitoring the development of colorectal carcinoma in patients with UC. A brief review of the recent literatures, however, has disclosed that the value of these modern techniques in the follow up surveillance of patients with UC of long standing is rather limited and that none of these measures should be used in isolation for the early detection of colorectal carcinoma arising in UC, or for selecting candidates for colectomy. Rather, the possible role of these modern techniques appears to be as a tool for elucidating the mechanism of colorectal
carcinogenesis
in patients with UC.
...
PMID:The value of mucin histochemistry, autoradiography and analysis of cellular DNA content for cancer surveillance in patients with ulcerative colitis. 268 3
Qualitative changes of glycoconjugates in luminal surface and goblet cell
mucin
from colon mucosa of 1,2-dimethylhydrazine (DMH)-treated rats were studied. Eight fluoresceinated lectins were used: Dolichos biflorus (DBA), Glycine max (SBA), Triticum vulgare (WGA), Limax flavus (LFA), Arachis hypogaea (PNA), Griffonia simplicifolia-I (GS-I), Ulex europaeus-I (UEA-I) and Canavalia ensiformis (Con A). The lectin-binding patterns were studied in tumors arising in proximal and distal portions of the colon, in transitional mucosa (TM) and in mucosa distant from tumors. Lectin reactivity observed in mucosa of DMH-treated rats was compared with that obtained in colon mucosa of control rats. In tumors and non-neoplastic mucosa of DMH-treated rats the reactivity of DBA, SBA, WGA, LFA, GS-I and Con A were similar to that in the mucosa of control rats. In contrast, important changes were observed in the reactivity of UEA-I and PNA. Contrary to the staining in the control mucosa, UEA-I bound intensely to all carcinomas and PNA to 50% and 60% of carcinomas arising in proximal and distal colon, respectively. Moreover, in TM and mucosa distant from tumors, UEA-I and PNA also differed in their binding patterns to that obtained in the colonic mucosa of the control rats. UEA-I- and PNA-binding to luminal surface and UEA-I-binding to the
mucin
of distal colonic mucosa from DMH-treated rats was similar to that observed in rat fetal colon suggesting a reappearance of a fetal-type pattern. Contrarily, PNA-reactivity in goblet cell and carcinoma
mucin
is a unique feature of colonic
carcinogenesis
not present during fetal development.
...
PMID:Lectin-binding sites in neoplastic and non-neoplastic colonic mucosa of 1,2-dimethylhydrazine-treated rats. 268 74
The effect of dietary wheat bran consumption on the anticarcinogenic action of tetragastrin upon colon
carcinogenesis
induced by azoxymethane was investigated in 122 inbred Wistar rats. Rats were given a control fiber-free diet or the same basal diet plus 20% wheat bran. From week 5, they were given 250 micrograms per kg body weight of tetragastrin in depot form every other day until the end of the experiment at week 45. Prolonged administration of tetragastrin resulted in a significant reduction of the incidence and number of colonic tumors per rat in the group given the fiber-free diet. The adenocarcinomas that did develop in this group had high
mucin
-producing activity, unlike the cancers produced in controls without tetragastrin. However, administration of tetragastrin had little or no influence on the incidence, number or histology of colonic tumors in the group given basal diet plus wheat bran. Dietary supplementation with wheat bran alone had little or no effect on the development or histology of colonic tumors. Before and during the administration of carcinogens, addition of fiber to the diet resulted in a significant fall in the colonic pH and a significant increase in the crypt column length, but administration of tetragastrin did not have an additive effect on the crypt column length in rats fed diet supplemented with fiber.
...
PMID:Inhibition by tetragastrin of experimental carcinogenesis in rat colon: effect of wheat bran consumption. 282 45
Dietary fibers may tend to enhance or inhibit chemically induced experimental colon cancer, depending on the particular fiber consumed. This study examined the relationship between colonic thymidine kinase enzyme activity and
mucin
histochemistry and the reported effects of various dietary fibers on chemically induced colon
carcinogenesis
. Fiber-supplemented diets containing fibers reported to inhibit (wheat bran) or enhance (guar gum, carrageenan) chemically induced colon
carcinogenesis
in the rat were selected. Four groups of male Fischer 344 rats consumed 10% wheat bran, 5% guar gum, 5% carrageenan, or fiber-free diets ad libitum for 4 weeks. At the completion of the treatment period, the distal 12 cm of colonic mucosa was scraped off and homogenized for determination of thymidine kinase activity, and a 0.5-cm section of midcolon was processed by the high-iron diamine/Alcian blue method for
mucin
histochemistry. Final animal weights did not differ significantly among groups. Thymidine kinase enzyme specific activity (mumole thymidine phosphate formed x 10(6)/min/mg protein, means +/- SEMs) was not significantly different in the fiber-free, wheat bran, and guar gum groups (10.98 +/- 1.50, 7.41 +/- 1.09, and 9.11 +/- 2.04, respectively) but was markedly elevated at 41.84 +/- 4.65 in the carrageenan group (alpha less than 0.001). Mucin histochemistry failed to reveal any significant differences among dietary groups.
...
PMID:Alterations in colonic thymidine kinase enzyme activity induced by consumption of various dietary fibers. 284 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>